A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
Open Access
- 27 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (5), 708-714
- https://doi.org/10.1038/sj.bjc.6605815
Abstract
Background: Most men with elevated levels of prostate-specific antigen (PSA) do not have prostate cancer, leading to a large number of unnecessary biopsies. A statistical model based on a panel of four kallikreins has been shown to predict the outcome of a first prostate biopsy. In this study, we apply the model to an independent data set of men with previous negative biopsy but persistently elevated PSA. Methods: The study cohort consisted of 925 men with a previous negative prostate biopsy and elevated PSA (⩾3 ng ml−1), with 110 prostate cancers detected (12%). A previously published statistical model was applied, with recalibration to reflect the lower positive biopsy rates on rebiopsy. Results: The full-kallikrein panel had higher discriminative accuracy than PSA and DRE alone, with area under the curve (AUC) improving from 0.58 (95% confidence interval (CI): 0.52, 0.64) to 0.68 (95% CI: 0.62, 0.74), PP=0.003). Application of the panel to 1000 men with persistently elevated PSA after initial negative biopsy, at a 15% risk threshold would reduce the number of biopsies by 712; would miss (or delay) the diagnosis of 53 cancers, of which only 3 would be Gleason 7 and the rest Gleason 6 or less. Conclusions: Our data constitute an external validation of a previously published model. The four-kallikrein panel predicts the result of repeat prostate biopsy in men with elevated PSA while dramatically decreasing unnecessary biopsies.Keywords
This publication has 46 references indexed in Scilit:
- A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, RotterdamClinical Cancer Research, 2010
- Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent ReplicationJournal of Clinical Oncology, 2010
- Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigenCancer, 2010
- Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK populationBMC Urology, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, SwedenBMC Medicine, 2008
- Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate BiopsyJournal of Urology, 2008
- Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control studyBMC Medicine, 2008
- REPEAT SCREENING FOR PROSTATE CANCER AFTER 1-YEAR FOLLOWUP IN 984 BIOPSIED MENJournal of Urology, 1998
- THE EFFECT OF PROSTATE VOLUME ON THE YIELD OF NEEDLE BIOPSYJournal of Urology, 1998